Plexāā collaborates with Panasonic Manufacturing UK for contract manufacturing of their BLOOM⁴³ medical device
London, UK – 15 January 2025 – Plexāā, a London-based medical device startup, is thrilled to announce a new partnership with Panasonic Manufacturing UK as their contract manufacturer for the award-winning BLOOM⁴³ medical device.
The BLOOM⁴³ platform is designed to help patients prepare for breast cancer surgery and reconstruction by harnessing the power of supraphysiological preconditioning. This technique intermittently heats the skin causing the release of heat-shock proteins which in turn cause vasodilation and increased blood flow to the area. This has been shown to reduce wound healing complications in proof-of-concept clinical trials.
Recently honoured with the prestigious Femtech Product of the Year award from MedTech World, the BLOOM⁴³ device is currently being trialled at Stanford University Hospital, California and the company is preparing for a market launch in the U.S. in spring 2025.
With over 1 million breast surgeries performed annually in the US alone, the collaboration between Plexāā and Panasonic Manufacturing UK is expected to significantly accelerate the production and scaling of this innovative healthcare solution.
Panasonic Manufacturing UK have just expanded their operations to include a state-of-the-art RE100 application, based on its own hydrogen fuel cell technology it is designed to run the Home appliance facility,100% on renewable energy, the first of its kind in Europe. Robert Blowers, Managing Director of Panasonic Manufacturing UK, commented:
"We are proud to partner with Plexāā on this exciting project. This collaboration not only highlights our ability to work across industries but also demonstrates our precision manufacturing expertise. We look forward to delivering high-quality products that will have a meaningful impact to patients."
Dr. Saahil Mehta, Founder of Plexāā, added:
"Partnering with Panasonic Manufacturing UK marks a crucial milestone for us. Their renowned expertise in manufacturing excellence & commitment to green manufacturing will enable us to efficiently bring the device to market and scale up globally in-line with demand."
The collaboration is underway with the first manufactured products expected early 2025.
